• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体内注射地塞米松植入物治疗与急性视网膜坏死相关的黄斑囊样水肿。

Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis.

作者信息

Majumder Parthopratim Dutta, Biswas Jyotirmay, Ambreen Asra, Amin Rowayda, Pannu Zahedur Rahman, Bedda Ahmed Magdy

机构信息

Medical and Vision Research Foundations, Sankara Nethralaya, 18, College Road, Chennai, 600 006, Tamil Nadu, India.

Ophthalmology department, Faculty of Medicine, Alexandria University, 42 Memphis street, Camp Caesar, Apt #5, Alexandria, Egypt.

出版信息

J Ophthalmic Inflamm Infect. 2016 Dec;6(1):49. doi: 10.1186/s12348-016-0116-x. Epub 2016 Dec 23.

DOI:10.1186/s12348-016-0116-x
PMID:28012104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5182243/
Abstract

BACKGROUND

Acute retinal necrosis is a rare but devastating ocular condition. We report two cases of acute retinal necrosis in immunocompetent patients, complicated by cystoid macular oedema and treated with intravitreal dexamethasone (OZURDEX®) implant.

RESULTS

Two patients diagnosed with acute retinal necrosis were treated with intravenous acyclovir. Both of them developed cystoid macular oedema following resolution of viral retinitis. Ocular condition of the first patient was further complicated by central serous chorioretinopathy. Under unavoidable circumstances, cystoid macular oedema in both the patients was treated with intravitreal dexamethasone implant with great caution. Resolution of cystoid macular oedema without recurrence of viral retinitis was noted in the long-term follow-up.

CONCLUSIONS

Findings of the case report should be interpreted cautiously, and extreme caution should be exercised prior deciding the management with a corticosteroid implant in patients with viral retinitis. However, intravitreal dexamethasone implant can be a useful option in selected patients with cystoid macular oedema in acute retinal necrosis.

摘要

背景

急性视网膜坏死是一种罕见但具有破坏性的眼部疾病。我们报告了两例免疫功能正常患者发生急性视网膜坏死的病例,这些病例并发了黄斑囊样水肿,并接受了玻璃体内地塞米松(Ozurdex®)植入治疗。

结果

两名被诊断为急性视网膜坏死的患者接受了静脉注射阿昔洛韦治疗。他们在病毒性视网膜炎消退后均出现了黄斑囊样水肿。第一名患者的眼部情况因中心性浆液性脉络膜视网膜病变而进一步复杂化。在不可避免的情况下,两名患者的黄斑囊样水肿均极为谨慎地接受了玻璃体内地塞米松植入治疗。在长期随访中,观察到黄斑囊样水肿消退且病毒性视网膜炎未复发。

结论

该病例报告的结果应谨慎解读,在决定对病毒性视网膜炎患者使用皮质类固醇植入物进行治疗之前应格外谨慎。然而,对于急性视网膜坏死伴有黄斑囊样水肿的特定患者,玻璃体内地塞米松植入可能是一种有用的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b82d/5182243/9a606c44d11d/12348_2016_116_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b82d/5182243/840e6037e147/12348_2016_116_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b82d/5182243/23ab61a9ef12/12348_2016_116_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b82d/5182243/9a606c44d11d/12348_2016_116_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b82d/5182243/840e6037e147/12348_2016_116_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b82d/5182243/23ab61a9ef12/12348_2016_116_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b82d/5182243/9a606c44d11d/12348_2016_116_Fig3_HTML.jpg

相似文献

1
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis.玻璃体内注射地塞米松植入物治疗与急性视网膜坏死相关的黄斑囊样水肿。
J Ophthalmic Inflamm Infect. 2016 Dec;6(1):49. doi: 10.1186/s12348-016-0116-x. Epub 2016 Dec 23.
2
Successful treatment with repeated dexamethasone implant injections for recurrent macular edema after acute retinal necrosis.急性视网膜坏死继发复发性黄斑水肿经反复地塞米松植入注射治疗成功。
J Ophthalmic Inflamm Infect. 2022 Oct 21;12(1):33. doi: 10.1186/s12348-022-00310-5.
3
SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.玻璃体内注射Ozurdex®治疗视网膜静脉阻塞合并黄斑囊样水肿的频域光学相干断层扫描图像特征
Eur J Ophthalmol. 2011 Sep-Oct;21(5):631-6. doi: 10.5301/EJO.2011.7428.
4
[Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].Ozurdex®地塞米松玻璃体内植入物治疗葡萄膜炎性黄斑囊样水肿的耐受性和短期疗效:对克莱蒙费朗教学医院进行的52次注射的回顾性研究
J Fr Ophtalmol. 2016 Jan;39(1):1-4. doi: 10.1016/j.jfo.2015.07.009. Epub 2015 Nov 23.
5
Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review.玻璃体内注射地塞米松植入物治疗羟氯喹视网膜病变所致黄斑囊样水肿:病例报告及文献综述
BMC Ophthalmol. 2018 Dec 6;18(1):310. doi: 10.1186/s12886-018-0985-x.
6
Dexamethasone intravitreal implant for treatment of persistent macular oedema in Birdshot retinochoroidopathy.地塞米松玻璃体内植入物治疗鸟枪弹样视网膜脉络膜病变中的持续性黄斑水肿。
Arch Soc Esp Oftalmol. 2016 Mar;91(3):138-41. doi: 10.1016/j.oftal.2015.10.012. Epub 2015 Dec 15.
7
Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy.地塞米松玻璃体内植入物治疗紫杉醇治疗继发的黄斑囊样水肿
Am J Ophthalmol Case Rep. 2020 Mar 7;18:100653. doi: 10.1016/j.ajoc.2020.100653. eCollection 2020 Jun.
8
Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report.玻璃体内注射阿柏西普(阿瓦斯汀)治疗视网膜色素变性相关性黄斑囊样水肿,尽管对雷珠单抗(兰尼单抗)反应甚微:一例报告
Case Rep Ophthalmol. 2016 Sep 7;7(2):389-397. doi: 10.1159/000448427. eCollection 2016 May-Aug.
9
Quantification of fluid resorption from diabetic macular oedema with foveal serous detachment after dexamethasone intravitreal implant (Ozurdex ) in a pregnant diabetic.妊娠糖尿病患者玻璃体内植入地塞米松(Ozurdex)后伴黄斑中心凹浆液性脱离的糖尿病性黄斑水肿液体吸收的定量分析
Acta Ophthalmol. 2017 May;95(3):324-325. doi: 10.1111/aos.13282. Epub 2016 Oct 24.
10
Cytomegalovirus Retinitis Associated With Intravitreal Dexamethasone Implant Injection.玻璃体内注射地塞米松植入剂相关的巨细胞病毒性视网膜炎
J Vitreoretin Dis. 2023 Dec 27;8(2):215-219. doi: 10.1177/24741264231221325. eCollection 2024 Mar-Apr.

引用本文的文献

1
Tocilizumab for Silicone Oil-Induced Recalcitrant Cystoid Macular Edema in a Patient with Recurrent Acute Retinal Necrosis-Associated Retinal Detachment.托珠单抗治疗复发性急性视网膜坏死相关视网膜脱离患者硅油诱导的顽固性黄斑囊样水肿
Ocul Immunol Inflamm. 2025 Jun 18:1-4. doi: 10.1080/09273948.2025.2519849.
2
The application of dexamethasone implants in uveitis treatment.地塞米松植入物在葡萄膜炎治疗中的应用。
Front Med (Lausanne). 2024 Jun 28;11:1402396. doi: 10.3389/fmed.2024.1402396. eCollection 2024.
3
Successful treatment with repeated dexamethasone implant injections for recurrent macular edema after acute retinal necrosis.

本文引用的文献

1
Long-term outcomes in patients undergoing vitrectomy for retinal detachment due to viral retinitis.因病毒性视网膜炎导致视网膜脱离而接受玻璃体切除术患者的长期预后。
Clin Ophthalmol. 2015 Jul 16;9:1307-14. doi: 10.2147/OPTH.S87644. eCollection 2015.
2
Use of intravitreal triamcinolone for the treatment of optic nerve edema in a patient with acute retinal necrosis: case report.玻璃体内注射曲安奈德治疗急性视网膜坏死患者视神经水肿:病例报告
Retin Cases Brief Rep. 2015 Spring;9(2):102-3. doi: 10.1097/ICB.0000000000000100.
3
Intravitreal triamcinolone acetonide as an adjuvant in the management of acute retinal necrosis.
急性视网膜坏死继发复发性黄斑水肿经反复地塞米松植入注射治疗成功。
J Ophthalmic Inflamm Infect. 2022 Oct 21;12(1):33. doi: 10.1186/s12348-022-00310-5.
4
Advances in the Diagnosis and Management of Acute Retinal Necrosis.急性视网膜坏死的诊断与治疗进展
Ann Eye Sci. 2020 Sep;5. doi: 10.21037/aes-2019-dmu-09. Epub 2020 Sep 15.
5
Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature.玻璃体内注射地塞米松植入剂作为一种用于治疗眼部疾病的缓释给药装置:文献综述
Pharmaceutics. 2020 Jul 26;12(8):703. doi: 10.3390/pharmaceutics12080703.
6
Acute retinal necrosis following dexamethasone intravitreal implant (Ozurdex®) administration in an immunocompetent adult with a history of HSV encephalitis: a case report.免疫功能正常的单纯疱疹病毒性脑炎病史成人应用地塞米松玻璃体内植入剂(Ozurdex®)后发生急性视网膜坏死:病例报告。
BMC Ophthalmol. 2020 Jun 22;20(1):247. doi: 10.1186/s12886-020-01514-w.
玻璃体内曲安奈德作为急性视网膜坏死治疗的辅助手段。
Can J Ophthalmol. 2014 Jun;49(3):279-82. doi: 10.1016/j.jcjo.2014.03.010.
4
Viral retinitis following intraocular or periocular corticosteroid administration: a case series and comprehensive review of the literature.眼内或眼周注射皮质类固醇激素后发生的病毒性视网膜炎:病例系列及文献综述
Ocul Immunol Inflamm. 2014 Jun;22(3):175-82. doi: 10.3109/09273948.2013.866256. Epub 2014 Mar 21.
5
Emerging concepts in the management of acute retinal necrosis.急性视网膜坏死的治疗新观点。
Br J Ophthalmol. 2013 May;97(5):545-52. doi: 10.1136/bjophthalmol-2012-301983. Epub 2012 Dec 12.
6
Herpetic necrotizing retinitis following flucinolone acetonide intravitreal implant.疱疹性坏死性视网膜炎继发于氟轻松醋酸酯眼内植入。
Ocul Immunol Inflamm. 2011 Feb;19(1):72-4. doi: 10.3109/09273948.2010.520404. Epub 2010 Oct 31.
7
Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbidities.患有易患医学合并症的患者在玻璃体内注射曲安奈德后发生病毒性视网膜炎。
Am J Ophthalmol. 2010 Mar;149(3):433-40.e1. doi: 10.1016/j.ajo.2009.10.019.
8
An unusual case of central serous chorioretinopathy in a patient with acute retinal necrosis.急性视网膜坏死患者发生中心性浆液性脉络膜视网膜病变的罕见病例。
Ocul Immunol Inflamm. 2008 May-Jun;16(3):109-11. doi: 10.1080/09273940802056299.
9
Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗葡萄膜炎患者难治性黄斑水肿的一项初步研究。
Retina. 2008 Jan;28(1):41-5. doi: 10.1097/IAE.0b013e318156db75.
10
Intravitreal bevacizumab for treatment of uveitic macular edema.玻璃体内注射贝伐单抗治疗葡萄膜炎性黄斑水肿。
Ophthalmology. 2007 Aug;114(8):1574-1579.e1. doi: 10.1016/j.ophtha.2006.11.028. Epub 2007 Mar 23.